Sagar S. Patel, MD
Patel, Sagar
Assistant Professor, Huntsman Cancer Institute
Huntsman Cancer Institute
Online Profile:
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
Dr. Tantravahi has received his medical degree from Guntur medical college, India. He then completed Internal Medicine residency and Hematology and Oncology fellowship training at University of Utah Hospital. His clinical interests include multiple myeloma, stem cell transplantation, and myeloproliferative neoplasm. Research interests are targeted therapy in CML and myeloproliferative neoplasms.
Here are the session recordings and the presentations for the 2023 Omaha Patient and Family Hybrid Conference.
Dr. Salman Fazal will gives a brief AML overview and then answers questions from participants. The question and answer session is recorded here.
In this webinar, Dr. Lourdes Mendez discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2022 meeting. Research findings are explained along with the potential impact of this research on understanding and treating MDS and AML. This is an advanced scientific presentation. The question and answer session is included in this recording.
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
A small portion of adults in remission from a deadly blood cancer had persisting mutations detected, which predicted their risk of death from having the cancer return
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
